Biological disease‐modifying drugs for rheumatoid arthritis. Issue 4 (6th May 2020) - Chaplin, Steve
Abstract : There are now nine biological disease‐modifying antirheumatic drugs (bDMARDs) available for the treatment of rheumatoid arthritis – seven monoclonal antibodies and two fusion proteins. This article summarises their indications, efficacy, place in therapy and adverse effects.